Young people’s decisions about biologic therapies: who influences them and how?
Objectives. Young people with inflammatory arthritis can have severe disease warranting biologic therapy. They face complex treatment decisions, with profound consequences. This study aimed to explore the influence of individuals outside the care team (trusted others) on the treatment decisions made...
Main Authors: | Hart, Ruth I., Foster, Helen E., McDonagh, Janet E., Thompson, Ben, Kay, Lesley, Myers, Andrea, Rapley, Tim |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473768/ |
Similar Items
-
Being as Normal as Possible: How Young People Ages 16–25 Years Evaluate the Risks and Benefits of Treatment for Inflammatory Arthritis
by: Hart, Ruth I., et al.
Published: (2016) -
Ethics – Who needs them?
by: Tim, Marshall
Published: (2003) -
Talking About Looking: Three Approaches to Interviewing Carers of People With Rheumatoid Arthritis About Information Seeking
by: Lee, Richard Philip, et al.
Published: (2015) -
What do young people with rheumatic conditions in the UK think about research involvement? A qualitative study
by: Suzanne Parsons, et al.
Published: (2018-05-01) -
What do young people with rheumatic disease believe to be important to research about their condition? A UK-wide study
by: Suzanne Parsons, et al.
Published: (2017-07-01)